Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness

Contraception

Volumn 93, Issue 1, 2016, Pages 17-24

  Whiteman, Maura K ^a   Jeng, Gary ^a   Samarina, Anna ^b   Akatova, Natalia ^b   Martirosyan, Margarita ^b   Kissin, Dmitry M ^a   Curtis, Kathryn M ^a   Marchbanks, Polly A ^a   Hillis, Susan D ^a   Mandel, Michele G ^a   Jamieson, Denise J ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b St Petersburg AIDS Center   (Russian Federation)

Author keywords

Antiretroviral agents therapeutic use; CD4 lymphocyte count; Contraceptive agents; Female administration and dosage adverse effects; HIV seropositivity complications drug therapy mortality

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CONTRACEPTIVE AGENT; DESOGESTREL PLUS ETHINYLESTRADIOL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; ANTIRETROVIRUS AGENT; DELAYED RELEASE FORMULATION;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONDOM; CONTRACEPTIVE BEHAVIOR; COPPER INTRAUTERINE DEVICE; DISEASE COURSE; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE CONDOM; MULTICENTER STUDY; PATIENT SAFETY; PROSPECTIVE STUDY; RISK ASSESSMENT; RUSSIAN FEDERATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; DELAYED RELEASE FORMULATION; DRUG INTERACTION; HIV INFECTIONS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE CONTRACEPTIVE DEVICE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CONDOMS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; DRUG INTERACTIONS; FEMALE; HIV INFECTIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; INTRAUTERINE DEVICES; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84951064319     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2015.07.003     Document Type: Article

References (22)

1. E. Stringer, and E. Antonsen Hormonal contraception and HIV disease progression Clin Infect Dis 47 7 2008 945 951
2. E.M. Stringer, J. Levy, M. Sinkala, B.H. Chi, I. Matongo, N. Chintu, and et al. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial AIDS 23 11 2009 1377 1382
3. S.J. Phillips, K.M. Curtis, and C.B. Polis Effect of hormonal contraceptive methods on HIV disease progression: a systematic review AIDS 27 5 2013 787 794
4. R. Heffron, N. Mugo, K. Ngure, C. Celum, D. Donnell, E. Were, and et al. Hormonal contraceptive use and risk of HIV-1 disease progression AIDS 27 2 2013 261 267
5. World Health Organization Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, June 2013 2013 World Health Organization Geneva
6. D. Hubacher, J. Liku, J. Kiarie, J. Rakwar, P. Muiruri, J. Omwenga, and et al. Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya J Int AIDS Soc 16 2013 18448
7. C.B. Polis, G. Nakigozi, V. Ssempijja, F.E. Makumbi, I. Boaz, S.J. Reynolds, and et al. Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda Contraception 86 6 2012 725 730
8. J.H. Chu, S.J. Gange, K. Anastos, H. Minkoff, H. Cejtin, M. Bacon, and et al. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy Am J Epidemiol 161 9 2005 881 890
9. M.K. Whiteman, D.M. Kissin, A. Samarina, K.M. Curtis, N. Akatova, P.A. Marchbanks, and et al. Determinants of contraceptive choice among women with HIV AIDS 23 Suppl. 1 2009 S47 S54
10. World Health Organization Medical Eligibility for Contraceptive Use: Fourth Edition, 2009 2010 World Health Organization Geneva
11. M.H. Cohen, A.L. French, L. Benning, A. Kovacs, K. Anastos, M. Young, and et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy Am J Med 113 2 2002 91 98
12. C.B. Polis, M.J. Wawer, N. Kiwanuka, O. Laeyendecker, J. Kagaayi, T. Lutalo, and et al. Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda AIDS 24 12 2010 1937 1944
13. C.S. Morrison, P.L. Chen, I. Nankya, A. Rinaldi, B. Van Der Pol, Y.R. Ma, and et al. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe J Acquir Immune Defic Syndr 57 2 2011 157 164
14. L. Lavreys, J.M. Baeten, J.K. Kreiss, B.A. Richardson, B.H. Chohan, W. Hassan, and et al. Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women J Infect Dis 189 2 2004 303 311
15. P.H. Kilmarx, K. Limpakarnjanarat, J. Kaewkungwal, R. Srismith, S. Saisorn, W. Uthaivoravit, and et al. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand J Infect Dis 181 5 2000 1598 1606
16. E.M. Stringer, M. Giganti, R.J. Carter, W. El-Sadr, E.J. Abrams, and J.S. Stringer Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative AIDS 23 Suppl. 1 2009 S69 S77
17. H.E. Cejtin, L. Jacobson, G. Springer, D.H. Watts, A. Levine, R. Greenblatt, and et al. Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women AIDS 17 11 2003 1702 1704
18. B.A. Richardson, P.A. Otieno, D. Mbori-Ngacha, J. Overbaugh, C. Farquhar, and G.C. John-Stewart Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women AIDS 21 6 2007 749 753
19. S. Allen, R. Stephenson, H. Weiss, E. Karita, F. Priddy, L. Fuller, and et al. Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda J Womens Health (Larchmt) 16 7 2007 1017 1027
20. Study Group for the MRC Collaborative Study Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland Sex Transm Infect 75 1999 247 252
21. World Health Organization, Hormonal Contraceptive Methods for Women at High Risk for HIV and Living with HIV 2014 Guidance Statement 2014 World Health Organization Geneva
22. M.D. Hughes, D.S. Stein, H.M. Gundacker, F.T. Valentine, J.P. Phair, and P.A. Volberding Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring J Infect Dis 169 1 1994 28 36